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Stone heterogeneity index as the 
standard deviation of Hounsfield 
units: A novel predictor for shock-
wave lithotripsy outcomes in ureter 
calculi
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Jung3, Jong Kyou Kwon4 & Kang Su Cho5
We investigated whether stone heterogeneity index (SHI), which a proxy of such variations, was defined 
as the standard deviation of a Hounsfield unit (HU) on non-contrast computed tomography (NCCT), can 
be a novel predictor for shock-wave lithotripsy (SWL) outcomes in patients with ureteral stones. Medical 
records were obtained from the consecutive database of 1,519 patients who underwent the first session 
of SWL for urinary stones between 2005 and 2013. Ultimately, 604 patients with radiopaque ureteral 
stones were eligible for this study. Stone related variables including stone size, mean stone density 
(MSD), skin-to-stone distance, and SHI were obtained on NCCT. Patients were classified into the low 
and high SHI groups using mean SHI and compared. One-session success rate in the high SHI group 
was better than in the low SHI group (74.3% vs. 63.9%, P = 0.008). Multivariate logistic regression 
analyses revealed that smaller stone size (OR 0.889, 95% CI: 0.841–0.937, P < 0.001), lower MSD (OR 
0.995, 95% CI: 0.994–0.996, P < 0.001), and higher SHI (OR 1.011, 95% CI: 1.008–1.014, P < 0.001) 
were independent predictors of one-session success. The radiologic heterogeneity of urinary stones or 
SHI was an independent predictor for SWL success in patients with ureteral calculi and a useful clinical 
parameter for stone fragility.
Despite the widespread acceptance and high success rate of shock-wave lithotripsy (SWL) for urinary stones, 
some calculi are found to be partially or completely resistant, requiring ancillary procedures with additional 
costs1. Several stone characteristics including stone size, mean stone density (MSD), and skin-to-stone distance 
(SSD) have been suggested to optimize and predict SWL outcomes.
MSD is well-known as a potentially useful independent predictor of SWL outcomes2–13. MSD is the mean 
value of the Hounsfield units (HUs) of each pixel in a certain stone area that can be easily determined from 
non-contrast computed tomography (NCCT) using a picture archiving and communication system (PACS)14. 
Generally, a PACS can also provide additional pixel statistics such as the minimum, maximum, and standard 
deviation of HU values. In statistics, the standard deviation is a measure that is used to quantify the amount of 
variation or dispersion of a set of data values, and a high standard deviation indicates that the data points are 
spread out over a wider range of values. Similarly, a high standard deviation of HUs may suggest heterogeneity in 
stone composition.
As shown in Fig. 1, because the composition of urinary stones can vary even though they have a similar MSD, 
we postulated that a heterogeneous stone may be more fragile than a homogeneous stone. Herein, we defined the 
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stone heterogeneity index (SHI) as the standard deviation of stone density on NCCT, and investigated whether 
SHI can be a novel predictor for SWL outcomes in patients with ureteral stones.
Results
Demographic analysis. The mean age of total patients was 51.92 ± 14.50 years. The distribution of ureteral 
stone locations was comprised of 492 cases of upper ureter stones (81.5%), 42 cases of mid-ureter stones (7.0%), 
and 70 cases of lower ureter stones (11.5%). The mean stone size was 9.12 ± 3.89 mm, and the mean MSD and 
SHI were 710.25 ± 269.65 HU and 229.45 ± 99.62 HU, respectively. The mean SSD was 109.96 ± 19.31 mm. The 
one-session success and one-session stone-free rates were 68.9% and 66.2%, respectively (Table 1).
Comparison between the low and high SHI groups. All patients were divided into low and high SHI 
groups according to the mean SHI. In terms of age, sex, stone location, size, and SSD, there was no significant 
difference between the two groups. MSD was significantly higher in the high SHI group than in the low SHI group 
(817.80 ± 247.02 HU vs. 612.23 ± 251.76 HU, P < 0.001). Nevertheless, the one-session success and stone-free 
rates in the high SHI group were higher than in the low SHI group (74.3% vs. 63.9%, P = 0.008 in one-session 
success rate; 70.5% vs. 62.3%, P = 0.043 in one-session stone-free rate; Table 1).
Factors affecting the one-session success and stone-free status. Univariate and multivariate 
logistic regression models were generated for one-session success and stone-free status. The multivariate model 
revealed that smaller stone size (OR 0.889, 95% Confidence Interval [CI]: 0.841–0.937, P < 0.001), lower MSD 
(OR 0.995, 95% CI: 0.994–0.996, P < 0.001), and higher SHI (OR 1.011, 95% CI: 1.008–1.014, P < 0.001) were 
independent predictors of one-session success. Similarly, stone size (OR 0.886, 95% CI: 0.839–0.933, P < 0.001), 
MSD (OR 0.996, 95% CI: 0.995–0.997, P < 0.001), and SHI (OR 1.008, 95% CI: 1.005–1.010, P < 0.001) also had 
an independent impact on one-session stone-free status (Table 2).
Figure 1. Schematic diagram showing the compositional heterogeneity of urinary calculi. All three stones 
demonstrate the same mean stone density (MSD) of 900 HU but their stone heterogeneity index (SHI) is 
different.
Total patients Low SHIa High SHIa P-Value
No. of patients 604 316 288
Sex (M:F) 394:210 204:112 190:98 0.780b
Mean Age (yrs) 51.92 ± 14.50 52.17 ± 14.92 51.65 ± 14.05 0.663c
Location (%) 0.103b
 Upper 492 (81.5) 250 (79.1) 242 (84.0) –
 Mid 42 (7.0) 21 (6.6) 21 (7.3) –
 Lower 70 (11.5) 45 (14.3) 25 (8.7) –
Stone size (mm) 9.12 ± 3.89 9.04 ± 4.56 9.21 ± 3.00 0.567c
SSD (mm) 109.96 ± 19.31 110.10 ± 19.94 109.80 ± 18.63 0.850c
MSD (HU) 710.25 ± 269.65 612.23 ± 251.76 817.80 ± 247.02 < 0.001c
SHI (HU) 229.45 ± 99.62 155.50 ± 51.95 310.58 ± 72.54 < 0.001c
One-session success (%) 416 (68.9) 202 (63.9) 214 (74.3) 0.008b
One-session stone-free (%) 400 (66.2) 197 (62.3) 203 (70.5) 0.043b
Table 1.  Clinical data on total patients and patients with low and high stone heterogeneity indices. SSD: 
skin-to-stone distance, MSD: mean stone density, SHI: stone heterogeneity index. aLow and high SHI groups 
were divided using mean SHI (229.45). bPearson’s Chi-squared test with Yates’ continuity correction. cStudent’s 
or Welch’s two-sample t-test.
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Impact of SHI on SWL outcomes according to stone size and MSD. In patients with a stone size 
≥ 10 mm, the one-session success rate was 50.2%, and SHI was significantly different between those with suc-
cess and failure (279.92 ± 115.66 HU vs. 204.99 ± 85.85 HU, P < 0.001). However, there was no difference in SHI 
according to the success or failure in patients with a stone size < 10 mm (Table 3). Meanwhile, one-session success 
rates were 75.0% in patients with a MSD < 1000 HU versus 38.0% in patients with a MSD ≥ 1000 HU. In patients 
with a MSD ≥ 1000 HU, SHI was significantly higher in cases with one-session success than in the cases with 
failure (308.02 ± 91.87 HU vs. 251.48 ± 54.51 HU, P = 0.001; Table 4).
Discussion
In the current study, we introduced the concept of radiologic heterogeneity of a urinary stone based on a HU 
measurement in NCCT and demonstrated the clinical significance of SHI in the management of patients with 
a ureteral stone. To the best of our knowledge, this is the first report dealing with this novel clinical factor, and 
we revealed that SHI was an independent predictor of SWL outcomes in ureteral stones. In general, urinary 
stones with a larger stone size (i.e., >10 mm) or a higher MSD (i.e., >1000 HU) have been deemed to be resistant 
to SWL, and stone size seems to be the most influential factor in predicting SWL outcomes1,15. Our results are 
in agreement with prior studies. Nevertheless, in certain stones with a higher SHI, favorable outcomes can be 
expected even though a stone may possess conventionally unfavorable clinical features, such as a larger stone size 
or a higher MSD (Tables 3 and 4). We believe that SHI can be a useful clinical parameter for stone fragility and can 
play a complementary role for such a clinical prediction in addition to stone size and MSD. In addition, SHI can 
be readily measured using the currently available PACS without additional equipment.
MSD has been widely used during the last decade as an important parameter to characterize urinary stones 
for both research and clinical practice16. However, MSD is only an arithmetical average that cannot represent the 
heterogeneity of stone composition, as shown in Fig. 1. Conversely, the standard deviation of a random varia-
ble, statistical population, data set, or probability distribution is the square root of its variance. SHI is an index 
Univariate Multivariate
OR 95% CI P-value OR 95% CI P-value
One-session success
 Age (year) 0.995 0.983–1.007 0.394
 Sex (Male) 0.831 0.574–1.195 0.323
 Stone size (mm) 0.832 0.789–0.874 < 0.001 0.889 0.841–0.937 < 0.001
 SSD (mm) 0.999 0.990–1.008 0.769
 MSD (HU) 0.997 0.996–0.998 < 0.001 0.995 0.994–0.996 < 0.001
 SHI (HU) 1.004 1.002–1.005 < 0.001 1.011 1.008–1.014 < 0.001
One–session stone-free
 Age (year) 0.991 0.979–1.003 0.128
 Sex (Male) 0.822 0.573–1.174 0.285
 Stone size (mm) 0.832 0.790–0.875 < 0.001 0.886 0.839–0.933 < 0.001
 SSD (mm) 1.000 0.991–1.008 0.992
 MSD (HU) 0.997 0.996–0.998 < 0.001 0.996 0.995–0.997 < 0.001
 SHI (HU) 1.002 1.000–1.004 0.017 1.008 1.005–1.010 < 0.001
Table 2. Univariate and multivariate logistic regression modelsa on one-session success and stone-free 
status in total patients with a ureteral stone. SSD: skin-to-stone distance, MSD: mean stone density, SHI: stone 
heterogeneity index. aA multivariate logistic regression model with forward stepwise selection was performed.
N (%) SHI (HU) P-value*
Stone size ≥ 10 mm (N = 229)
 One-session success
Yes 115 (50.2) 279.92 ± 115.66 < 0.001
No 114 (49.8) 204.99 ± 85.85
 One-session stone-free
Yes 109 (47.6) 274.62 ± 113.76 < 0.001
No 120 (52.4) 213.54 ± 94.76
Stone size < 10 mm (N = 375)
 One-session success
Yes 301 (80.3) 224.15 ± 102.60 0.180
No 74 (19.7) 210.23 ± 78.89
 One-session stone-free
Yes 291 (77.6) 221.43 ± 100.22 0.991
No 84 (22.4) 221.31 ± 84.30
Table 3. Comparison of stone heterogeneity index (SHI) in one-session success and stone-free status 
according to stone size. SHI: stone heterogeneity index. *Student’s two-sample t-test for stone heterogeneity 
index in each group.
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presenting the radiological heterogeneity of a urinary stone defined as the standard deviation of HU in the region 
of interest, as aforementioned. Accordingly, SHI can represent the internal diversity of a stone, reflecting not only 
the heterogeneity of the stone’s composition but also the structural and morphological heterogeneity of a stone. 
There can be several explanations for the difference in SHI of urinary stones. First, urinary stones are generally 
not monocrystals, which can be a cause for SHI. Jing et al. reported a prospective analysis of urinary calculi com-
position by infrared spectroscopy with 625 patients in eastern China17. They showed that 37.4% of urinary stones 
are pure stones, but most urinary stones were mixed (62.6%) in which calcium oxalate was the most commonly 
found major component. Second, the internal structure and morphology of stones can vary, even though the 
composition of minerals is similar, which can also contribute to such differences in SHI value. Urinary stones 
present with a variety of gross appearances according to their contour irregularities, such as smoothly round, 
spiculated, and mulberry stones18. Meanwhile, the internal structure showing a heterogeneity of composition or 
cracks were also detected using NCCT even in stones with the same attenuation; cross-sectional images of such a 
stone can differ from mottled to lamellar structures19. In addition, there can be some empty space within urinary 
calculi structural irregularities. This space can be filled with water or air, which might be an important cause of 
heterogeneity of the attenuation index.
Conventionally, stone composition has been undoubtedly important in determining the efficacy of stone treat-
ment, especially SWL. The most dramatic differences have been found with radiolucent uric acid calculi (easily 
fragmented with SWL) and relatively radiolucent cysteine calculi (often refractory to SWL), which is useful infor-
mation in selecting stone treatment20. Accordingly, knowing the composition of urinary calculi is essential for 
deciding the optimal mode of treatment. Urine pH, the presence of crystals, urease-positive bacteria in the urine, 
a plain x-ray, and a history of urinary stones have long been used to predict the composition of stones21. During 
last two decades, the relationship between HU and stone composition has been investigated. Several studies 
demonstrated with an in vitro approach that stone composition could be predicted with high accuracy using HU 
and HU density (HU divided by the greatest transverse diameter)22–24. However, Toricelli et al. showed that there 
was an overlap between the HU values of cysteine and uric acid stones, making it difficult to differentiate these 
types of stones25. Such an overlap of values also precludes any more exact determination of stone composition 
by the MSD. In 2003, Williams et al. suggested that knowing the major composition of a stone may not allow 
adequate prediction of its fragility in lithotripsy treatment, and variations in internal stone structure, including 
secondary mineral composition, may be a significant cause of this variability in stone fragility26.
The relationship between CT parameters and SWL outcomes has also been extensively investigated, and rep-
resentative studies are summarized in Table 5. In the NCCT era of urinary stone management, lots of interest 
has been raised about MSD and SSD as novel predictors of SWL outcomes. Most studies showed that MSD was 
significantly associated with SWL success, but only two studies showed no relationship between MSD and SWL 
outcomes27,28. El-Nahas showed that a MSD > 1000 HU was a significant independent predictor of SWL fail-
ure. Thus, they maintained that an alternative treatment should be offered for patients with a MSD > 1000 HU5. 
Interestingly, in cases with a MSD > 1000 HU, the success or stone-free groups demonstrated significantly higher 
SHIs than the failure group in our study (Table 4). However, the role of SSD as a predictor of SWL success remains 
controversial. Approximately half of the published studies have advocated the role of SSD in predicting SWL out-
comes, but the other studies have failed to demonstrate a significant relationship between SSD and SWL success.
This study has some inherent limitations due to its retrospective design, which may have introduced sampling 
bias; however, we built a relatively large cohort for ureteral stone disease. In addition, to overcome this type of 
limitation, subjects of our study were only ureters stones to elucidate the impact of SHI on SWL outcomes more 
clearly. In renal stone, anatomical considerations including location of calyx and renal pelvic stone or infundibu-
lopelvic angle can be another bias. Two different generating machines may be a bias, but there were no statistical 
difference in each period. Another concern is that the clinical significance of SHI may be limited due to its OR 
from the logistic regression analysis, which may be a major obstacle to using SHI in a clinical setting. However, 
multivariate analysis demonstrated that the predictive power for treatment outcomes was in order of stone size, 
SHI, and MSD based on odds ratios (Table 2). In addition, SHI was a significant predictor for successful out-
comes in patients with stone sizes of ≥ 10 mm (Table 3), and there was a significant difference in SHI between 
N (%) SHI (HU) P-value*
MSD ≥ 1000 HU (N = 100)
 One-session success
Yes 38 (38.0) 308.02 ± 91.87 0.001
No 62 (62.0) 251.48 ± 54.51
 One-session stone-free
Yes 36 (36.0) 299.45 ± 87.65 0.016
No 64 (64.0) 258.07 ± 64.30
MSD < 1000 HU (N = 504)
 One-session success
Yes 378 (75.0) 232.69 ± 109.81 < 0.001
No 126 (25.0) 185.19 ± 95.89
 One-session stone-free
Yes 364 (72.2) 229.64 ± 106.64 0.001
No 140 (27.8) 197.85 ± 98.55
Table 4.  Comparison of stone heterogeneity index (SHI) in one-session success and stone-free status 
according to mean stone density. MSD: mean stone density, SHI: stone heterogeneity index. *Student’s two-
sample t-test for stone heterogeneity index in each group.
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success and failure groups regardless of MSD (Table 4). Meanwhile, the relationship among stone size, MSD, and 
SHI is a very important and interesting issue. Correlation analyses demonstrated no relationship between stone 
size and SHI (r = 0.060; P = 0.114) while showing a positive correlation between stone size and MSD (r = 0.317; 
P < 0.001). Taken together, although the predictive power of SHI seems to be limited and weaker than stone size, 
SHI can play a complementary role in the prediction of treatment outcomes, similar to MSD.
However, further studies with a prospective design are needed to confirm our observation on the relationship 
between SHI and SWL outcomes, and a clinically applicable cut-off value of SHI should be determined for the 
selection of proper candidates for SWL treatment. In addition, experimental studies in conjunction with chemical 
and structural analysis of urinary calculi would be helpful for a thorough understanding of the clinical signifi-
cance of SHI.
In summary, the radiologic heterogeneity of a urinary stone or SHI was independently associated with SWL 
success in patients with ureteral calculi, thus SHI can be a useful clinical parameter for stone fragility. SHI may be 
affected by the compositional heterogeneity in urinary calculi, as well as their structural and morphological heter-
ogeneity. SHI will play a promising role when determining a treatment modality in patients with a urinary stone, 
and especially when selecting the proper SWL candidates from the patients with a stone of large size or high MSD.
Methods
Patient cohort. Medical records were obtained from a consecutive database of patients who had undergone 
the first session of SWL between November 2005 and December 2013 in the Severance Hospital, Seoul, Korea. 
During this period, a total of 1,519 patients were registered in our database. Inclusion criteria for the current study 
were a 4- to 20-mm stone in the ureter and radiopaque calculi on a plain x-ray. Patients who did not undergo 
a NCCT scan were excluded. Ultimately, 604 patients with ureter calculi were eligible for the current analyses. 
The Institutional Review Board of Severance Hospital approved this study protocol (Approval No. 4-2014-0465).
Shock-wave lithotripsy. SWL was performed with an electroconductive lithotripter (EDAP Sonolith 
Praktis, Technomed, Lyon, France) until 2011; after 2012, the device was replaced by an electromagnetic gen-
erative lithotripter (Dornier Compact Delta II lithotripter, Dornier MedTech GmbH, Wessling, Germany). All 
patients were treated under fluoroscopic guidance. The number of shock waves per SWL session varied from 2500 
to 4000 at a rate of 60 to 90 shock waves per minute with a launch intensity ranging from 16 to 55 MPa.
Stone characteristics on non-contrast computed tomography. Stone characteristics include 
the location, size, SSD, MSD, and SHI. We used the GE Centricity system (GE Healthcare Bio-Sciences Corp., 
Piscataway, NJ, USA) during the measurement procedure. The stone size was determined from the largest stone 
diameter on the axial or coronal plane of NCCT, and the SSD measurement was taken from the point of the 
largest stone diameter at a 45° angle from the horizontal. HU was measured on the magnified, axial NCCT 
image from the point of the largest stone diameter, where the elliptical region of interest incorporated the largest 
cross-sectional area of the stone without including the adjacent soft tissue. MSD was defined as the mean value of 
HU in the region of interest, and SHI was defined as the standard deviation of HU in the same region of interest 
Reference Year Country Size Stone location MSD (HU) SSD (mm)
Predictors of success treatment
MSD SSD
Pareek et al.27 2005 USA 64 Lower calyx 660/950b 81.2/115.3b No Yes
Gupta et al.2 2005 India 112 Renal and proximal ureter – – Yes –
Yoshida et al.3 2006 Japan 62 Renal and proximal ureter 562/742
a – Yes –
Perks et al.4 2007 Canada 76 Renal and ureter 684/1034a – Yes –
El-Nahas et al.5 2007 Egypt 120 Renal 709/776a 91/117a Yes No
Weld et al.6 2007 USA 200 Renal 662/728a 106/106a Yes No
Perks et al.7 2008 Canada 111 Renal 801/1092a 100/111a Yes Yes
Kacker et al.8 2008 USA 325 Renal and ureter 522/724 – Yes –
Jacobs et al.30 2008 USA 85 Renal and ureter 692.9/812.4c 103.9/101.0c – No
Bandi et al.9 2008 USA 94 Renal and ureter 475/544d 108.5/102.9d Yes No
Ng et al.10 2009 Hong Kong 94 Proximal ureter 534/626a 102.3/104.4a Yes Yes
Patel et al.28 2009 USA 83 Renal 787.7/803.2e 83.3/107.7e No Yes
Wiesenthal et al.11 2010 Canada 422 Renal and ureter 767.2 113.6 Yes Yes
Choi et al.12 2012 Korea 153 Ureter 756.5/833.8f 103.2/101.0f Yes No
Tanaka et al.13 2013 Japan 75 Renal and ureter 670.3 104 Yes No
Present 2014 Korea 604 Ureter 710.3 110 Yes No
Table 5.  Review of the literature on the relationship between stone characteristics and shock-wave 
lithotripsy outcomes. aSuccess group vs. failure group. bStone-free vs. residual stone (p < 0.05 in both MSD and 
SSD). cStone-free vs. residual stone (p > 0.05 in both MSD and SSD). SSD was measured from the center of the 
stone to the level of the skin at 30°. dStone-free vs. residual stone (p > 0.05 in both MSD and SSD). eStone-free 
vs. residual stone (p > 0.05 in MSD and p < 0.05 in SSD). fStone size ≤ 10 mm vs. > 10 mm.
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(Fig. 2). A successful SWL treatment of ureteral and renal calculi was defined as those patients who were rendered 
stone-free or had asymptomatic, clinically insignificant residual fragments ≤ 3 mm in the largest stone diameter 
2 weeks after a single SWL treatment29, as measured by a simple x-ray without the need for auxiliary measures 
within a 3-month follow-up period. Stone-free status was defined as when a simple X-ray analysis determined 
that patients had a calcification-free 2-week period after a single SWL treatment.
Statistical analysis. Statistical comparisons of continuous variables from the patient demographic infor-
mation were carried out using either a Student’s or Welch’s two-sample t-test or the Wilcoxon rank-sum test. 
Categorical variables were compared using Pearson’s chi-squared test. Univariate and multivariate logistic regres-
sions with a binomial method were carried out for significant factors of one-session success and stone-free sta-
tus. Statistical analyses were performed using R software (version 3.0.3, R Foundation for Statistical Computing, 
Vienna, Austria; http://www.r-project.org).
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